Skip to Main Content

Paper Details

Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232.
Leukemia
10
2022
AALL0232, AYA, AYA B-ALL, B-lymphoblastic leukemia, Children, HR, HR B-ALL, HR-ALL, acute lymphoblastic leukemia, adult, marrow relapses, patients
Author NameAffiliation
Meenakshi DevidasSt. Jude Children's Research Hospital
Julie M Gastier-FosterBaylor College of Medicine
Julie M Gastier-FosterBaylor College of Medicine
Stephen P HungerChildren's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania
Stephen P HungerChildren's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania
Mignon L LohBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco
  • 1 - 6

Datasets